Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.19.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities    
Net income $ 808,931 $ 800,209
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization expense 482,497 420,154
Deferred income taxes, net (25,731) 3,998
Loss on extinguishment of debt 3,988 6,346
Provision for bad debts and inventory obsolescence 2,852 3,420
Gain on involuntary conversion of assets (2,800)  
Share-based compensation expense 82,070 88,797
Net foreign currency adjustments (4,326) (4,494)
Changes in operating assets and liabilities:    
Accounts receivable, net (12,741) (5,649)
Inventories (4,681) (14,237)
Prepaid expenses and other assets 1,786 (34,668)
Accounts payable (86,525) 3,003
Accrued expenses and other liabilities (27,504) 136,954
Advance ticket sales 262,938 316,268
Net cash provided by operating activities 1,480,754 1,720,101
Cash flows from investing activities    
Additions to property and equipment, net (615,985) (1,361,678)
Issuance of loans (36,392)  
Cash received on settlement of derivatives 289 64,796
Cash paid on settlement of derivatives (556)  
Other 7,719 755
Net cash used in investing activities (644,925) (1,296,127)
Cash flows from financing activities    
Repayments of long-term debt (2,882,354) (1,233,499)
Proceeds from long-term debt 2,652,000 1,491,352
Proceeds from employee related plans 18,203 26,642
Net share settlement of restricted share units (20,935) (13,840)
Purchases of treasury shares (349,860) (463,505)
Early redemption premium (117) (5,154)
Deferred financing fees (9,359) (115,699)
Net cash used in financing activities (592,422) (313,703)
Net increase in cash and cash equivalents 243,407 110,271
Cash and cash equivalents at beginning of period 163,851 176,190
Cash and cash equivalents at end of period $ 407,258 $ 286,461